Home Full Prescribing Information Safety Information Adverse Events Promius™ Pharma
Epiceram Skin Barrier Emulsion

EpiCeram has demonstrated comparable efficacy to Cutivate® Cream (fluticasone propionate 0.05%) in improving the signs and symptoms of AD at day 28.

  • Learn about a head-to-head clinical study, which showed that there was no statistically significant difference in efficacy between EpiCeram and fluticasone propionate 0.05% at day 28

EpiCeram has five proposed mechanisms of action (MOA) that help to normalize the skin barrier.

EpiCeram can be used on all age groups, without
any restriction on face or intertriginous area application.

Head to Head Study Results
IMPORTANT SAFETY INFORMATION EpiCeram is contraindicated in persons with a known hypersensitivity to any component of the formulation. After application, a temporary tingling sensation may occur. For more information, please see full prescribing information.